Why Did Lixte Biotechnology Gap Up 100% Today? – Benzinga
Lixte Biotechnology (NASDAQ: LIXT) shares rose more than 100% percent in Friday’s premarket session. Lixte holdings is a drug discovery company focused on creating drugs that will help patients with cancer. Lixte’s main product...
LIXT Stock: 8 Things to Know About Lixte Biotechnology As Shares Blast Off –...
Lixte Biotechnology (NASDAQ:LIXT) stock is heading higher on Friday despite a lack of news concerning the company. Source: Shutterstock
The rise in price for LIXT stock comes alongside heavy trading of the shares...
Researchers Pinpoint the Workings behind Liver Regeneration
The liver is the only solid organ that uses regenerative mechanisms to ensure that the liver-to-bodyweight ratio is always at 100% of what is required for body homeostasis. When the liver is injured beyond...
The Life Oncolytic, with Stephen Russell
Some remarkable successes in the clinic give Russell—and his commercial and pharmaceutical partners, including Regeneron—the belief that this can become an increasingly important aspect of cancer therapy . . .
The post The Life Oncolytic,...
Video: ‘One more tool in our toolbox’: The case for crop biotechnology – Genetic...
The GLP Needs Your Help
It is easier than ever for advocacy groups to spread disinformation on pressing science issues, such as the ongoing coronavirus pandemic. No, vaccines are not harmful. Yes, the use of...
New, more reliable testing program rolled-out to hospital staff to curb Covid transmission rates
Frontline staff at Norfolk and Norwich University Hospitals (NNUH) are among the first in the country to benefit from the rollout of more accurate saliva tests in a bid to curb Covid transmission rates....
Lethal house lures reduce incidence of malaria in children
Credit: Daniel Lesher, Penn State
UNIVERSITY PARK, Pa. — A new type of housing modification can reduce malaria incidence among children by around 40-50%, according to an...
Flush with Cash, Foresite Aims to Live Up to Its Name
Foresite's new $775-million Fund V as well as a $193.5-million fund for nurturing earliest-stage startups, called the Fund V Opportunity Fund, bring the firm's assets under management to approximately $4 billion . . .
The...
Insilico Medicine discovers novel preclinical candidate to address idiopathic pulmonary fibrosis
Insilico Medicine has demonstrated a breakthrough in Artificial Intelligence ("AI") and drug discovery -- linking together generative chemistry and biology for the first time -- to discover a novel preclinical candidate addressing idiopathic pulmonary...
UM scientists achieve breakthrough in culturing corals and sea anemones cells
Credit: Mike Connelly
MIAMI–Researchers have perfected the recipe for keeping sea anemone and coral cells alive in a petri dish for up to 12 days. The new study, led by scientists at the University of...
